Mark W. Empie

1.6k total citations
16 papers, 1.2k citations indexed

About

Mark W. Empie is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark W. Empie has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Mark W. Empie's work include Diet, Metabolism, and Disease (4 papers), Phytoestrogen effects and research (3 papers) and Diet and metabolism studies (3 papers). Mark W. Empie is often cited by papers focused on Diet, Metabolism, and Disease (4 papers), Phytoestrogen effects and research (3 papers) and Diet and metabolism studies (3 papers). Mark W. Empie collaborates with scholars based in United States, Germany and China. Mark W. Empie's co-authors include Sam Z. Sun, M. Laskowski, Brent D. Flickinger, Patricia S. Williamson-Hughes, Ikunoshin Kato, Hai-mei Tian, Xiaobing Wang, Yi Liu, Wei Zhang and Mark Messina and has published in prestigious journals such as Journal of Molecular Biology, Biochemistry and Journal of Dairy Science.

In The Last Decade

Mark W. Empie

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Empie United States 14 501 429 273 252 230 16 1.2k
G. Vallette France 23 510 1.0× 179 0.4× 93 0.3× 214 0.8× 82 0.4× 57 1.3k
Xiaoqun Duan China 22 1.1k 2.2× 192 0.4× 143 0.5× 110 0.4× 193 0.8× 51 1.9k
Trevor Selwood United States 19 641 1.3× 182 0.4× 160 0.6× 254 1.0× 43 0.2× 29 1.4k
François Collard Belgium 20 555 1.1× 341 0.8× 66 0.2× 176 0.7× 155 0.7× 37 1.3k
Anna J. Furth United Kingdom 14 845 1.7× 272 0.6× 96 0.4× 378 1.5× 59 0.3× 26 1.6k
F. Novello Italy 22 766 1.5× 103 0.2× 88 0.3× 146 0.6× 163 0.7× 72 1.5k
Gérard Pieroni France 25 1.2k 2.3× 273 0.6× 54 0.2× 323 1.3× 60 0.3× 45 1.9k
Véronique Carrière France 21 651 1.3× 194 0.5× 57 0.2× 223 0.9× 132 0.6× 51 1.4k
Chi‐Sun Wang United States 23 889 1.8× 338 0.8× 46 0.2× 207 0.8× 125 0.5× 38 2.0k
Kunihiko Saito Japan 20 484 1.0× 81 0.2× 86 0.3× 123 0.5× 118 0.5× 61 1.1k

Countries citing papers authored by Mark W. Empie

Since Specialization
Citations

This map shows the geographic impact of Mark W. Empie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Empie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Empie more than expected).

Fields of papers citing papers by Mark W. Empie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Empie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Empie. The network helps show where Mark W. Empie may publish in the future.

Co-authorship network of co-authors of Mark W. Empie

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Empie. A scholar is included among the top collaborators of Mark W. Empie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Empie. Mark W. Empie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sun, Sam Z. & Mark W. Empie. (2012). Fructose metabolism in humans – what isotopic tracer studies tell us. Nutrition & Metabolism. 9(1). 89–89. 222 indexed citations
2.
Sun, Sam Z., G. Harvey Anderson, Brent D. Flickinger, Patricia S. Williamson-Hughes, & Mark W. Empie. (2011). Fructose and non-fructose sugar intakes in the US population and their associations with indicators of metabolic syndrome. Food and Chemical Toxicology. 49(11). 2875–2882. 63 indexed citations
3.
Sun, Sam Z., Brent D. Flickinger, Patricia S. Williamson-Hughes, & Mark W. Empie. (2010). Lack of association between dietary fructose and hyperuricemia risk in adults. Nutrition & Metabolism. 7(1). 16–16. 73 indexed citations
4.
Korgaonkar, Chandrashekhar K., et al.. (2009). A 13-week sub-chronic dietary toxicity study of a cruciferin-rich canola protein isolate in rats. Food and Chemical Toxicology. 47(10). 2645–2654. 16 indexed citations
5.
Korgaonkar, Chandrashekhar K., et al.. (2009). A 13-week dietary toxicity study in rats of a Napin-Rich Canola Protein Isolate. Regulatory Toxicology and Pharmacology. 55(3). 394–402. 13 indexed citations
6.
Wang, Xiaobing, Yi Liu, Hai-mei Tian, et al.. (2008). Effects of Dietary Flaxseed Lignan Extract on Symptoms of Benign Prostatic Hyperplasia. Journal of Medicinal Food. 11(2). 207–214. 47 indexed citations
8.
Zhang, Wei, Xiaobing Wang, Yi Liu, et al.. (2007). Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. British Journal Of Nutrition. 99(6). 1301–1309. 165 indexed citations
9.
Williamson-Hughes, Patricia S., Brent D. Flickinger, Mark Messina, & Mark W. Empie. (2006). Isoflavone supplements containing predominantly genistein reduce hot flash symptoms. Menopause The Journal of The North American Menopause Society. 13(5). 831–839. 87 indexed citations
10.
Fontaine, Johannes, Mark W. Empie, Sigvard Eriksson, et al.. (2000). Liquid Chromatographic Determination of Lysine, Methionine, and Threonine in Pure Amino Acids (Feed Grade) and Premixes: Collaborative Study. Journal of AOAC International. 83(4). 771–783. 23 indexed citations
11.
Empie, Mark W., et al.. (1990). Synthesis of L-phenylalanine methyl ester. Industrial & Engineering Chemistry Research. 29(4). 651–659. 8 indexed citations
12.
Zaks, A. S., et al.. (1988). Potentially commercial enzymatic processes for the fine and specialty chemical industries. Trends in biotechnology. 6(11). 272–275. 17 indexed citations
13.
Laskowski, Michael, Ikunoshin Kato, Wojciech Ardelt, et al.. (1987). Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues. Biochemistry. 26(1). 202–221. 169 indexed citations
14.
15.
Weber, E., Wolfram Bode, Robert Huber, et al.. (1982). Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. Journal of Molecular Biology. 158(3). 515–537. 128 indexed citations
16.
Empie, Mark W. & Nicholas Melachouris. (1978). Determination of Orotic Acid in Whey and Modified Whey Products. Journal of Dairy Science. 61(6). 683–687. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026